Image For Activity Cover
Methamphetamine in the Era of Fentanyl: Toxicities and Pharmacotherapies
Phillip Coffin, MD, University of California San Francisco
Target Audience
Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, and pharmacists.
Credit Designations Available
AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit, CEUs for psychology, and Pharmacy CE credit.
Module Description
Morbidity and mortality related to methamphetamine use have been escalating dramatically. While these shifts began before fentanyl was established as a street opioid, trends have become even more profoundly concerning as fentanyl has come to dominate most markets around the United States. Treatment of methamphetamine use disorder is limited, with strong data for contingency management and modest data for a growing number of medications. This activity will review available treatment options and future possibilities for addressing an escalating trend in methamphetamine mortality and morbidity. Since the concept of methamphetamine or stimulant overdose is often overlooked or difficult to assess, especially in comparison to the trademark signs of opioid overdose like respiratory depression, this webinar will illustrate the symptoms of acute stimulant toxicity events and the medical interventions necessary to treat them. Learners will gain a better understanding of the intersections between stimulant use and opioid use disorder and how to best recognize overdose events related to polysubstance use.
Educational Objectives
  • Describe trends in morbidity and mortality related to methamphetamine.
  • Explain the distinctions between non-fatal and fatal acute methamphetamine toxicity.
  • Utilize evidence supporting interventions for treatment of methamphetamine use disorder.
Method of participating in the learning process

In order to receive maximum credit, learners must: 

1. Review the materials provided.
2. Complete knowledge-based assessment questions to assess both prior knowledge and knowledge change following the activity
3. Complete an evaluation to assess satisfaction and plans for individual and/or team practice change.
4. Follow instructions at the end of the course regarding how to retrieve a certificate.* 

*Credit will not be awarded unless all components of the program are completed.  Partial credit will not be awarded.

Availability: On-Demand
Expires on 04/12/2024
Cost: FREE
Credit Offered:
1 CME Credit
1 PA-CME Credit
1 Other Professionals Credit
1 Psychology (APA) Credit
1 Nursing Credit
1 Pharmacy Credit
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible (in part) by grant nos. 1H79TI086770 and 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For Buprenorphine Training Inquiries, email PCSS-MOUD.


Powered By